Indoramin

  • TRADE NAMES: Baratol (Amdipharm); Doralese Tiltab (GSK); Orfidora; Vidora
  • INDICATIONS: Hypertension, alpha blockade, benign prostatic hyperplasia
  • CLASS: Alpha 1 adrenoreceptor antagonist
  • HALF-LIFE: 5 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Anesthetics, Antidepressants, Antihypertensives, Anxiolytics, Beta-blockers, Calcium channel blockers, Diuretics, MAO inhibitors, Moxisylyte

Our database has 10 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GENITOURINARY.
OTHER.


Page last updated 09/03/2019

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top